Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Source:http://linkedlifedata.com/resource/pubmed/id/21498742

Download in:

View as

General Info

PMID
21498742